The Alliance for a Stronger FDA has published its “ask” for Fiscal Year 2025 funding for the U.S. Food and Drug Administration (FDA), which is $214 million more than the Presidential budget request submitted by FDA for FY 2025.
In light of recently confirmed cases of highly pathogenic avian influenza (HPAI) in U.S. dairy cows and now in one person, James (Jim) Jones, FDA Deputy Commissioner for Human Foods revealed that HPAI has become the “highest priority” within the agency’s Human Foods Program, and that the agency has set up a set up a dedicated Incident Management Team (IMT) to respond to the developing threat.
In an April 5 webinar, FDA Deputy Commissioner for Human Foods James (Jim) Jones spoke in great detail about the agency’s fiscal year (FY) 2025 Presidential budget request, and how portions of those funds will be allocated to meeting Human Foods Program goals.
In a recent webinar organized by the Alliance for a Stronger FDA, a top policy and legislation official from the U.S. Food and Drug Administration (FDA) provided insight to the agency’s approach to regulating cannabidiol (CBD) and kratom in foods and dietary supplements.
Eliminating redundancies, increasing efficiency, and cultivating a culture of collaboration were the main themes of a January 19 webinar featuring top U.S. Food and Drug Administration (FDA) officials, hosted by Alliance for a Stronger FDA to discuss the agency’s proposed reorganization.
On a webinar with the Alliance for a Stronger FDA, the U.S. Food and Drug Administration’s (FDA’s) Deputy Commissioner, Dr. Janet Woodcock, discussed FDA’s data and information processing modernization efforts.
